LeMaitre Vascular

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Earnings data Q3 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 2023 Cantor Global Healthcare Conference on Tuesday, September 26, 2023, at 11:40 AM ET in New York City.

LeMaitre to Present at the 2023 Cantor Global Healthcare Conference

LeMaitre Vascular's sales and profits surged in the second quarter. The company's dividend is supported by earnings.

Looking for Dividend Growth? Buy This Little-Known Healthcare Stock

Cigna

Cigna and LeMaitre each appear to have decent growth prospects. Both companies pay well-covered dividends to shareholders.

2 Healthcare Stocks That Could Help Make You a Fortune

LeMaitre Vascular's stock offers attractive long-term investment prospects, with recent consolidations offering an entry point for investors. The company reported record quarterly sales in Q2 and is expected to continue unlocking long-term value for shareholders. LMAT's investment in sales team expansion and continued asset growth contribute to its economic profitability and positive sentiment.

LeMaitre: Record Quarter, ASPs And Volumes Ratcheting Higher Equals Qualified Growth Outlook

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer David Roberts - President Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc. Aaron Wukmir - Lake Street Capital Markets Michael Petusky - Barrington Research Associates, Inc. Operator Welcome to the LeMaitre Vascular Q2 2023 Financial Results Conference Call. As a reminder, today's call is being recorded.

LeMaitre Vascular, Inc. (LMAT) Q2 2023 Earnings Call Transcript

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.29 per share a year ago.

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Beat Estimates

BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2023 results, announced a $0.14/share quarterly dividend and provided guidance.

LeMaitre Q2 2023 Financial Results

BURLINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in August.

LeMaitre to Present at Upcoming Investor Conferences in August

BURLINGTON, Mass., July 17, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2023 financial results on Tuesday, August 1, 2023, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

LeMaitre Will Announce Second Quarter 2023 Earnings Results August 1, 2023

Abbott Labs

Investors interested in Medical - Products stocks are likely familiar with Abbott (ABT) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck right now?

ABT vs. LMAT: Which Stock Should Value Investors Buy Now?

Quanex Building Products

Stellar Bancorp Inc

The iShares Micro-Cap ETF (NYSEARCA: IWC ) is the crème de la crème for finding the top micro-cap stocks to buy. The ETF tracks the performance of the Russell Microcap Index, a collection of the smallest securities in the small-cap Russell 2000 index.

3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential

LeMaitre continues to add value for shareholders on multiple fronts. The company's business economics support earnings and dividend growth. Looking ahead, the company could be worth $85 intrinsic value.

LeMaitre: Continues To Create Value, Breakout To New Highs

Advance Auto Parts

Clearway Energy

NextEra Energy

Analyst ratings are a wonderful contrarian indicator.

Why The Best Dividend Stocks Are Hated By Analysts

BURLINGTON, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in June.

LeMaitre to Present at Upcoming Investor Conferences in June

LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why

On Holding AG

Park-Ohio Holdings

ONON, PKOH and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 23, 2023.

Best Momentum Stocks to Buy for May 23rd

LeMaitre Vascular logged impressive sales growth in the first quarter. The company could maintain outsize payout growth in the future.

Is This Healthcare Stock a Buy for Dividend Growth Investors?

Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes LeMaitre Vascular (LMAT) a Strong Momentum Stock: Buy Now?

LeMaitre credited a beefed-up sales force and an uptick in hospital orders for higher numbers. The company grew revenue by 19% year over year in the first quarter.

Why Shares of LeMaitre Vascular Are Up Wednesday

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer David Roberts - President Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc. Frederick Wise - Stifel, Nicolaus & Company, Inc. Michael Petusky - Barrington Research Associates, Inc. Scott Henry - ROTH Capital Partners Operator Welcome to the LeMaitre Vascular Q1 2023 Financial Results Conference Call. As a reminder, today's call is being recorded.

LeMaitre Vascular, Inc. (LMAT) Q1 2023 Earnings Call Transcript

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.27 per share a year ago.

LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Beat Estimates

BURLINGTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2023 results, announced a $0.14/share quarterly dividend and provided guidance.

LeMaitre Q1 2023 Financial Results

Zimmer Biomet Hlds

Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck right now?

ZBH or LMAT: Which Is the Better Value Stock Right Now?

BURLINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, announced today it has entered into an agreement with Aziyo Biologics, Inc. (Nasdaq: AZYO) to become the exclusive distributor of Aziyo's cardiovascular patches in the United States. Under the agreement, LeMaitre will distribute the products for three years and has an option to acquire Aziyo's worldwide cardiovascular patch business during the second and third year of the term.

LeMaitre to Distribute Aziyo Biologics' Cardiovascular Patches

BURLINGTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2023 financial results on Tuesday, May 2, 2023, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

News for LeMaitre Vascular Stock (LMAT)